4
Changes in Ownership
Gain Therapeutics, Inc. Filed Acc 0001493152-24-011836
Chief Executive Officer gave up 6,085 shares (to pay taxes)
- Chief Executive Officer acquired 20,212 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Alder Matthias Chief Executive Officer | 2024-03-26 | Option exercise | +18,750 | 25,763 | D: show line 1 in the form | ||
| Alder Matthias Chief Executive Officer | 2024-03-26 | Option exercise | +825 | 26,588 | D: show line 2 in the form | ||
| Alder Matthias Chief Executive Officer | 2024-03-26 | Option exercise | +637 | 27,225 | D: show line 3 in the form | ||
| Alder Matthias Chief Executive Officer | 2024-03-26 | Shares withheld for taxes | −6,085 | $4.06 | $24,705 | 21,140 | D: show line 4 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Alder Matthias Chief Executive Officer | 2024-03-26 | Option exercise · Restricted Stock Units | −18,750 | 56,250 | D: show line 5 in the form | |||||
| Alder Matthias Chief Executive Officer | 2024-03-26 | Option exercise · Restricted Stock Units | −825 | 8,250 | D: show line 6 in the form | |||||
| Alder Matthias Chief Executive Officer | 2024-03-26 | Option exercise · Restricted Stock Units | −637 | 6,376 | D: show line 7 in the form |
Loading xslF345X05/ownership.xml…